Skip to main content
QuestionsResearchTagsGuidelinesLeaderboard
tachyDx Research Portal

Research tagged [emergency-medicine]

Every paper is generated from a real clinical discussion on tachyDx, peer-reviewed by verified physicians, and published with a unique TDX identifier. All contributors are credited.

DOIs registered viaCrossref
Published26Under ReviewFlagged
Clear filters

6 papers

TDX-2026-00026

Low-Titer Group O Whole Blood Resuscitation in Civilian Massive Hemorrhage: An Evidence Synthesis and Implementation Review

Massive hemorrhage remains a leading cause of preventable death in trauma. Traditional resuscitation protocols, often based on 1:1:1 component therapy (packed red blood cells, fresh frozen plasma, platelets), aim to mitigate trauma-induced coagulopathy. However, logistical challenges and delays associated with component preparation have prompted exploration of alternative strategies. Low-titer group O whole blood (LTOWB) has emerged as a promising option, offering a physiologically balanced resuscitation product. This paper synthesizes expert clinical perspectives and recent trial data regarding the transition to LTOWB in civilian trauma centers. Findings indicate that a hybrid approach, utilizing LTOWB for initial resuscitation units, can accelerate balanced resuscitation and improve hemostatic parameters. While logistical hurdles such as shelf life and inventory management persist, strategies for mitigation have been developed. Furthermore, LTOWB significantly reduces administrative errors and simplifies resuscitation protocols in high-stress environments. The role of dried plasma as a pre-hospital adjunct, particularly in settings with prolonged transport times or challenging cold chain logistics, is also discussed. The collective evidence suggests that LTOWB represents a valuable advancement in massive hemorrhage resuscitation, warranting careful consideration for integration into institutional protocols.

A physician-only Q&A platform where verified medical doctors share clinical knowledge, debate evidence, and build the knowledge base the world needs.

Powered by

Platform

  • Questions
  • Research
  • Tags
  • Guidelines
  • Leaderboard
  • Report a Bug

Ecosystem

  • Teams
  • Sponsors
  • Hiring
  • Publishing
  • CME
  • Data

Company

  • About
  • Support
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 Aethryva Deeptech Pvt Ltd. All rights reserved.

Crossref Member
2 contributors 82 votes 9 Apr 2026

TDX-2026-00020

DWI-FLAIR Mismatch and Large Vessel Occlusion in Wake-Up Stroke: A Synthesis of Expert Opinion and Evidence from a Clinical Case Discussion

Background: Wake-up stroke (WUS) presents a significant challenge in acute ischemic stroke management due to unknown symptom onset time, complicating eligibility for time-sensitive reperfusion therapies. Imaging-based selection, particularly diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) mismatch, has expanded treatment windows for intravenous thrombolysis (IVT), while advanced perfusion imaging guides mechanical thrombectomy (MT) in large vessel occlusion (LVO). This paper synthesizes expert clinical decision-making in a complex WUS case with DWI-FLAIR mismatch and LVO, integrating current evidence. Methods: This academic paper formalizes a clinical Q&A discussion from the tachyDx platform, involving two verified stroke neurologists and receiving 96 community peer votes. The discussion centered on a 67-year-old female with WUS, left hemiplegia, NIHSS 14, right M1 occlusion, DWI-FLAIR mismatch, and a large penumbra on CT perfusion. Results: Both experts advocated for immediate bridging IVT followed by MT. Divergence arose in IVT dosing: one expert recommended standard 0.9 mg/kg alteplase, citing potential for maximum thrombolytic effect in LVO, while the other preferred 0.6 mg/kg, aligning with regional protocols and improved safety profiles. Both acknowledged the role of good collaterals in delaying FLAIR changes, supporting the validity of the DWI-FLAIR mismatch. The patient achieved TICI 2c reperfusion and significant neurological improvement. Conclusions: This case highlights the evolving consensus on aggressive reperfusion strategies for WUS with favorable imaging. It underscores the ongoing debate regarding optimal IVT dosing in the context of bridging therapy for LVO, emphasizing the need for individualized treatment guided by comprehensive imaging and patient-specific factors.

2 contributors 96 votes 9 Apr 2026

TDX-2026-00013

Compartment Pressure Thresholds for Acute Compartment Syndrome in Tibia-Fibula Fractures: A Clinical Consensus and Evidence Synthesis

Acute compartment syndrome (ACS) represents a limb-threatening surgical emergency, frequently associated with closed long bone fractures such as those of the tibia and fibula. The diagnosis of ACS hinges on a combination of clinical findings and objective intracompartmental pressure (ICP) measurements; however, the precise interpretation of ICP thresholds, particularly the debate between absolute pressure values and the delta-P criterion, remains a subject of ongoing clinical contention. This paper synthesizes a clinical discussion originating from a community peer-reviewed platform, involving two expert physicians (Orthopedics & Trauma Surgery, Emergency Medicine) and validated by 46 peer votes, addressing the diagnostic utility of various ICP thresholds, the role of continuous monitoring, and the critical importance of clinical judgment in ACS management. A consensus emerged, strongly advocating for the primacy of clinical findings, such as disproportionate pain and pain on passive stretch, over strict adherence to numerical ICP thresholds. The index case, a 22-year-old male with a closed tibia-fibula fracture, underwent fasciotomy despite a delta-P (diastolic BP - ICP) of 40 mmHg, which typically would not meet traditional surgical criteria. Intraoperative findings confirmed muscle ischemia, and the patient subsequently achieved full functional recovery. Both contributing experts emphasized ICP measurements as an adjunct to clinical assessment and highlighted the significant risks associated with delayed consultation and reliance on an unreliable clinical examination in sedated or obtunded patients. This synthesis underscores that clinical judgment, guided by the classic '5 P's,' should primarily direct the decision for fasciotomy in suspected ACS, even when ICP measurements do not strictly align with established numerical criteria. Timely orthopedic consultation and a heightened awareness of situations compromising clinical assessment are paramount to prevent irreversible ischemic damage and optimize patient outcomes.

2 contributors 46 votes 6 Apr 2026

TDX-2026-00010

Differential Diagnosis and Management of Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: A Clinical Case and Community Consensus

Neuroleptic Malignant Syndrome (NMS) and Serotonin Syndrome (SS) represent life-threatening adverse drug reactions with significant clinical overlap, posing a considerable diagnostic challenge, particularly in patients receiving multiple psychotropic medications. This paper presents a detailed analysis of a 45-year-old male on haloperidol and fluoxetine who developed severe hyperthermia, rigidity, altered mental status, and elevated creatine phosphokinase (CPK), necessitating urgent differentiation and management. Through a community peer-reviewed clinical discussion involving two verified physicians and 59 peer votes, a consensus was reached on diagnostic criteria and therapeutic strategies. Key distinguishing features identified included the presence of lead-pipe rigidity and bradykinetic facies, a significantly elevated CPK level (12,400 U/L, peaking at 18,000 U/L), and a subacute onset over several days, which collectively favored a diagnosis of NMS. Management involved immediate discontinuation of all suspected agents, aggressive supportive care including intravenous hydration and cooling, and the initiation of dantrolene. The patient demonstrated clinical improvement with normalization of temperature and mental status, and resolution of renal dysfunction. This case highlights the critical importance of meticulous clinical assessment and a structured approach to management in complex neuroleptic- and serotonergic-induced toxicities, emphasizing the utility of specific pharmacological interventions tailored to the suspected syndrome while maintaining robust supportive care.

2 contributors 59 votes 6 Apr 2026

TDX-2026-00006

Management of Thyroid Storm with Severe Asthma: A Community Peer-Reviewed Clinical Consensus on Non-Beta-Blocker Rate Control and Adjunctive Therapies

Thyroid storm represents a life-threatening endocrine emergency characterized by exaggerated manifestations of thyrotoxicosis. Rapid heart rate control is critical, typically achieved with beta-adrenergic receptor blockers. However, the presence of severe comorbid conditions, such as severe asthma, can contraindicate standard beta-blocker therapy, posing a significant clinical challenge. This paper synthesizes a clinical discussion from the tachyDx community peer-review platform regarding the optimal management strategy for a 28-year-old male presenting with thyroid storm and severe asthma, specifically focusing on rate control alternatives and comprehensive adjunctive treatments. Methods: This case-based discussion was initiated by a verified endocrinologist on a specialized clinical Q&A platform, attracting input from another verified physician and garnering 68 community peer votes. The methodology involved expert clinical opinion exchange, evaluation of therapeutic alternatives, and consensus building on a complex patient presentation. The final management approach, which led to a successful clinical outcome, was subsequently shared and validated. Results: The consensus approach involved intravenous diltiazem for heart rate control, achieving a reduction from 156 to 94 bpm within four hours without precipitating bronchospasm. The comprehensive thyroid storm regimen included propylthiouracil (PTU), saturated solution of potassium iodide (SSKI), hydrocortisone, and cholestyramine. This multifaceted intervention resulted in a dramatic clinical improvement, with the Burch-Wartofsky score decreasing from 55 to 20 within three days. Conclusions: Diltiazem emerges as a safe and effective alternative for rapid heart rate control in thyroid storm patients with severe asthma where beta-blockers are contraindicated. The case reinforces the importance of a multi-modal therapeutic strategy targeting hormone synthesis, release, peripheral conversion, and enterohepatic recirculation, tailored to individual patient comorbidities.

2 contributors 68 votes 6 Apr 2026

TDX-2026-00005

Interpreting Elevated Cardiac Troponin in Chronic Kidney Disease: An Evidence-Based Framework from Community Peer Consensus

Background: The interpretation of elevated cardiac troponin levels in patients with chronic kidney disease (CKD) presents a significant diagnostic challenge in acute care settings. CKD patients frequently exhibit chronically elevated baseline troponin, complicating the differentiation between acute myocardial infarction (AMI), demand ischemia, and non-ischemic myocardial injury. This ambiguity often leads to diagnostic delays or inappropriate interventions, particularly in the context of atypical symptoms and a desire for early discharge. Methods: This consensus paper synthesizes expert opinions and clinical insights from a peer-reviewed discussion involving four verified physicians (emergency medicine, cardiology, nephrology, internal medicine) on the tachyDx platform, which garnered 73 community peer votes. The methodology involved structured responses to a clinical dilemma, followed by expert review and synthesis. Results: Key findings include the utility of an absolute delta troponin rise of ≥0.05 ng/mL over 3-6 hours, integrated with clinical context, to warrant urgent cardiac evaluation. High-sensitivity troponin assays were deemed more useful in CKD when serial measurements and CKD-specific cutoffs are applied. CT coronary angiography serves as a valuable gatekeeper for intermediate-risk patients with adequate renal function (eGFR ≥30 mL/min/1.73m²), while pharmacologic stress testing is preferred for advanced CKD. A structured risk stratification approach was developed, emphasizing the integration of ECG, hemodynamic status, and symptomology. Conclusions: An integrated, multi-modal approach, combining serial high-sensitivity troponin measurements with an absolute delta threshold, careful clinical assessment, and judicious use of advanced imaging, is crucial for accurate risk stratification and management of CKD patients with suspected acute coronary syndromes. Effective patient communication regarding diagnostic timelines is also vital.

4 contributors 73 votes 6 Apr 2026
Page 1 of 2Next →

Topics

Allpharmacology8critical-care7cardiology6emergency-medicine6oncology5pulmonology5nephrology4neurology4gastroenterology3immunology3hematology3surgery3infectious-disease3radiology2endocrinology2anesthesiology2hepatology2pediatrics2rheumatology2evidence-based-medicine1orthopedics1trauma1neonatology1psychiatry1internal-medicine1